Quantbot Technologies LP Pmv Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $1,070 - $5,742	870 Added 19.48%	5,336 $16,000
Q3 2023 Nov 07, 2023	SELL	$6.01 - $8.93 $13,222 - $19,646	-2,200 Reduced 33.0%	4,466 $27,000
Q2 2023 Aug 08, 2023	SELL	$3.94 - $6.27 $41,897 - $66,675	-10,634 Reduced 61.47%	6,666 $41,000
Q1 2023 May 12, 2023	BUY	$4.77 - $9.16 $55,303 - $106,201	11,594 Added 203.19%	17,300 $82,000
Q4 2022 Feb 13, 2023	BUY	$8.17 - $12.95 $46,618 - $73,892	5,706 New	5,706 $49,000
Q2 2022 Aug 09, 2022	BUY	$9.23 - $22.43 $17,130 - $41,630	1,856 New	1,856 $26,000
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $25,262 - $40,035	-1,700 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$19.99 - $30.24 $33,983 - $51,408	1,700 New	1,700 $39,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.